Question

Difficulty: MediumMenstrual Cycle Abnormalities and Contraception

A 16-year-old girl is brought to the outpatient clinic due to the absence of menarche. She reports no cyclical pelvic or lower abdominal pain. Her medical history is unremarkable, and she takes no medications. On physical examination, her height is at the 60th percentile and weight is at the 55th percentile. Breast development and pubic hair are both at Tanner stage 4. Pelvic examination reveals normal external female genitalia, but there is a shortened, blind-ending vaginal pouch and the cervix cannot be visualized. Arrange the following steps in the most appropriate sequential order for the diagnostic evaluation and management of this patient.

  1. 1Perform a pelvic ultrasound
  2. 2Obtain a serum karyotype and testosterone level
  3. 3Perform a renal ultrasound
  4. 4Initiate therapy with progressive vaginal dilators

Answer

The correct sequence is: Pelvic ultrasound -> Serum karyotype and testosterone level -> Renal ultrasound -> Initiate therapy with progressive vaginal dilators.
The correct sequence follows the standard diagnostic algorithmic approach for primary amenorrhea. When physical examination reveals a blind-ending vagina, pelvic ultrasound is the initial required step to verify the absence of the uterus. Next, karyotype and testosterone levels differentiate the two main causes of an absent uterus: MRKH (46,XX) and CAIS (46,XY). After definitively confirming MRKH, screening for known associations (renal anomalies via ultrasound) must occur. Finally, treatment with vaginal dilators is offered when the patient is ready to engage in sexual activity.

Step-by-Step Solution

1
Perform a pelvic ultrasound
Confirms the anatomical absence of normal Mullerian structures (uterus, cervix, upper vagina).
It is the least invasive and most critical first imaging step to anatomically classify the cause of primary amenorrhea when a blind vagina is noted on physical exam.
2
Obtain a serum karyotype and testosterone level
Establishes the diagnosis of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome vs Complete Androgen Insensitivity Syndrome (CAIS).
Both conditions present with an absent uterus and a blind vagina; karyotype (46,XX vs 46,XY) and testosterone levels (female vs male range) provide the definitive diagnosis.
3
Perform a renal ultrasound
Screens for associated urologic congenital anomalies.
Patients with MRKH have a high incidence (25-30%) of renal anomalies, such as unilateral renal agenesis or a horseshoe kidney, requiring screening upon diagnosis.
4
Initiate therapy with progressive vaginal dilators
Creates a functional neovagina.
Non-surgical dilation is the first-line and preferred treatment for vaginal agenesis, prioritized over surgical creation, and is started once diagnosis and screening are complete.

Key Concept

Evaluation of primary amenorrhea with normal breast development and an absent uterus requires sequential anatomical confirmation (ultrasound), genetic/endocrine diagnosis (karyotype/testosterone), screening for associated anomalies (renal ultrasound), and non-surgical management (vaginal dilators).
Rate this question